As promised, Mylan N.V. has proceeded to make formal bid to acquire Perrigo Co. plc in a deal valued at approximately $27 billion. Mylan said Monday that under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share.
Kevin Warren has joined NBTY Inc. as president of NBTY International.
Next spring, George Paz is slated to retire as chief executive officer of Express Scripts Holding Co. and be succeeded by president Tim Wentworth.
Mylan N.V. has announced the U.S. launch of drospirenone and ethinyl estradiol tablets (3 mg/0.03 mg), an oral contraceptive.
Kaz USA Inc. is providing another way to alleviate children’s cold and flu symptoms and help them get rest with the new Vicks Sweet Dreams Cool Mist Humidifier, which projects dream-themed images on the ceiling while restoring moisture to the air to ease breathing.
Pharmaceutical distributors Cardinal Health Inc. and AmerisourceBergen Corp. this week announced the election of new board members. Cardinal said that Nancy Killefer is slated to join its board as an independent director on Sept. 14. Most recently, she was senior partner of McKinsey & Co.
Next week, Mylan N.V. plans to make a formal offer directly to the shareholders of Perrigo plc to buy the company. Mylan said Tuesday that it aims to make the bid on Monday, Sept. 14. Under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each
After a seven-year absence, Hydrox sandwich cookies are being relaunched by Leaf Brands LLC. Leaf Brands kicked off the relaunch on Friday at its production facility in Vernon, Calif.
NeutriSci International Inc. has entered a national distribution agreement for its NeuEnergy chewable energy tablets with Rite Aid Corp., which has nearly 4,600 drug stores in 31 states and the District of Columbia.
Health care software, analytics and payment service provider Emdeon plans to rename as Change Healthcare to better reflect its diverse capabilities and solutions. The company said late Thursday that the rebranding is slated to begin in the fourth quarter of this year.
Sandoz has inaugurated a new era in medicine with the release of Zarxio, the first biosimilar of a biologic drug approved in the United States. The Novartis subsidiary said Thursday that Zarxio — a biosimilar of Amgen Corp.
Par Pharmaceutical has released testosterone gel 1%, a generic version of AndroGel 1% from AbbVie. Par said Wednesday that its testosterone gel 1% product is available in 2.5g and 5g aluminum foil packets containing 25 mg or 50 mg of testosterone, respectively.
Lannett Co. plans to acquire Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic drug subsidiary of UCB S.A., in a $1.23 billion deal. Lannett said late Wednesday that the acquisition will add a diversified commercial product portfolio of 18 products.
Hershey Co. has made its Ice Breakers mints available via the Amazon Dash Button, a miniature device that makes it easier for consumers to reorder their favorite products.
Sandoz has launched a rivastigmine patch, a treatment for dementia, in the U.S. market. The Novartis subsidiary said Wednesday that its rivastigmine transdermal system is an authorized generic version of the Exelon patch, marketed by Novartis Pharmaceuticals Corp.
Sundial Brands, the maker of natural beauty care brands SheaMoisture and Nubian Heritage, has sold a minority interest in the company to global investment firm Bain Capital Private Equity.
